Volume 104, Issue 10 pp. 3314-3318
RAPID COMMUNICATION

Does the Anesthetic Urethane Influence the Pharmacokinetics of Antifungal Drugs? A Population Pharmacokinetic Investigation in Rats

Francine Johansson Azeredo

Francine Johansson Azeredo

Pharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Search for more papers by this author
Sandra Elisa Hass

Sandra Elisa Hass

Pharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Search for more papers by this author
Pedro Sansone

Pedro Sansone

Pharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Search for more papers by this author
Hartmut Derendorf

Hartmut Derendorf

Department of Pharmaceutics, University of Florida, Gainesville, Florida

Search for more papers by this author
Teresa Dalla Costa

Teresa Dalla Costa

Pharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Search for more papers by this author
Bibiana Verlindo De Araujo

Corresponding Author

Bibiana Verlindo De Araujo

Pharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Telephone: +55-51-3308-5418; Fax: +55-51-3308-5437; E-mail: [email protected]Search for more papers by this author
First published: 18 June 2015

Abstract

The aim of this paper was to analyze the impact of anesthesia induced by urethane on pharmacokinetics (PK) parameters of fluconazole (FCZ), mostly eliminated via renal excretion and voriconazole (VRC), eliminated mainly by hepatic metabolism. FCZ and VRC PK were investigated after administration of 10 mg/kg i.v. and 5 mg/kg i.v. doses to awake and urethane anesthetized Wistar rats (n = 6 per group), respectively. After dosing, blood samples were collected up to 18 h (FCZ) or 12 h (VRC) and the plasma data analysis was performed using the software MONOLIX v. 4.2.2. The population PK parameters and microconstants were determined by fitting plasma concentration–time profiles to two-compartment model for FCZ and three-compartment model for VRC. Fitting of FCZ plasma profiles after dosing to awake and anaesthetized animals resulted in a volume of distribution (V) of 9.3 and 8.1 L/kg, and k10 values of 0.12 and 0.14 h−1, respectively. VRC plasma profiles in awake and anaesthetized showed V 8.7 of and 7.6 L/kg, and k10 of 0.15 and 0.16 h−1, respectively. No statistical differences between plasma PK parameters and microconstants for the same drug in both animal conditions studied were observed (α = 0.05). © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:3314–3318, 2015

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.